BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9754948)

  • 21. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
    Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
    Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
    Houston DMJ; Bugert JJ; Denyer SP; Heard CM
    PLoS One; 2017; 12(6):e0179291. PubMed ID: 28665969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.
    Brandt CR; Spencer B; Imesch P; Garneau M; Déziel R
    Antimicrob Agents Chemother; 1996 May; 40(5):1078-84. PubMed ID: 8723444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic testing of patient herpes simplex virus type 1 and 2 isolates for acyclovir resistance by a novel method based on real-time cell analysis.
    Caliaro O; Barbani MT; Klenja S; Morfin F; Frobert E; Gorgievski M; Steinlin-Schopfer J; Suter-Riniker F
    J Clin Virol; 2020 Apr; 125():104303. PubMed ID: 32163870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity of esterified alpha-lactalbumin and beta-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines.
    Sitohy M; Billaudel S; Haertlé T; Chobert JM
    J Agric Food Chem; 2007 Dec; 55(25):10214-20. PubMed ID: 17990848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
    Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
    Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus.
    Thompson KD
    Antiviral Res; 1998 Jul; 39(1):55-61. PubMed ID: 9754950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
    Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
    Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
    Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
    Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties.
    Hassan STS; Šudomová M; Berchová-Bímová K; Šmejkal K; Echeverría J
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31405197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral bioavailability and in vivo efficacy of the helicase-primase inhibitor BILS 45 BS against acyclovir-resistant herpes simplex virus type 1.
    Duan J; Liuzzi M; Paris W; Liard F; Browne A; Dansereau N; Simoneau B; Faucher AM; Cordingley MG
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1798-804. PubMed ID: 12760851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of interferon-alpha and acyclovir on herpes simplex virus type-1 ribonucleotide reductase.
    O'Brien WJ; Narasimhan J; Guy J; Tom P; Taylor JL
    Antiviral Res; 1998 May; 38(2):107-16. PubMed ID: 9707373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of benzo[a]phenothiazines with acyclovir against herpes simplex virus.
    Mucsi I; Molnár J; Motohashi N
    Int J Antimicrob Agents; 2001 Jul; 18(1):67-72. PubMed ID: 11463529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Chono K; Katsumata K; Suzuki H; Shiraki K
    Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
    Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
    J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.
    Park PJ; Antoine TE; Farooq AV; Valyi-Nagy T; Shukla D
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6373-81. PubMed ID: 23989188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potency of acyclovir can be markedly different in different cell types.
    Brand G; Schiavano GF; Balestra E; Tavazzi B; Perno CF; Magnani M
    Life Sci; 2001 Aug; 69(11):1285-90. PubMed ID: 11521752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.